Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03861780 · ClinicalTrials.gov registry record · Phase 3
Pilot Evaluation of Two Test Materials With a Positive Control When Used as a Patient Preoperative Skin Preparation
A Phase 3 study of Bacteria Microflora Reduction, sponsored by Professional Disposables International.
- Completed
- Registry status
- Phase 3
- Development phase
- 152
- Enrollment target
- 1
- Study location
NCT03861780 is a Phase 3 study of Bacteria Microflora Reduction that has completed, run by Professional Disposables International. The registered enrollment target is 152 participants. The trial reports 1 study location across 1 state.
The verdict
NCT03861780, a Phase 3 study of Bacteria Microflora Reduction, has completed, sponsored by Professional Disposables International.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 152 participants
- Enrollment target
- 1
- Study location
Study Summary
Comparative Study of Antimicrobial Effectiveness Evaluation of 26ml Project X, 5.1ml Project X and Prevantics Maxi Swabstick following ASTM E1173 - Standard Test Method for Evaluation of Preoperative, Precatheterization, or Preinjection Skin Preparations, ASTM International, West Conshohocken, Pennsylvania, 2015
Conditions Studied
Interventions
- DRUG Project X 26ml
- DRUG Project X 5.1ml
- DRUG Prevantics Maxi Swabstick
Study Locations (1)
Montana
- Bioscience Laboratories Inc - Bozeman
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 152 participants |
| Start Date | 2019-04-02 |
| Est. Completion | 2019-06-06 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03861780
The ClinicalTrials.gov registry entry for NCT03861780 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 152 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Professional Disposables International, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Bacteria Microflora Reduction appearing as the primary indexed condition, and to 3 interventions - of which Project X 26ml is the first listed.
NCT03861780 reports 1 study location spanning 1 distinct geographic area - top geographies include Montana.
Frequently Asked Questions
What is clinical trial NCT03861780 about?
NCT03861780 is a clinical study titled "Pilot Evaluation of Two Test Materials With a Positive Control When Used as a Patient Preoperative Skin Preparation". Comparative Study of Antimicrobial Effectiveness Evaluation of 26ml Project X, 5.1ml Project X and Prevantics Maxi Swabstick following ASTM E1173 - Standard Test Method for Evaluation of Preoperative, Precatheterization, or Preinjection Skin Preparations, ASTM International, West Conshohocken, Penns...
What is the current status of trial NCT03861780?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 152 participants. The study started on 2019-04-02. Estimated completion is 2019-06-06.
What conditions does trial NCT03861780 study?
This clinical trial studies the following conditions: Bacteria Microflora Reduction.
What interventions are being tested in trial NCT03861780?
The interventions under investigation include: Project X 26ml (DRUG), Project X 5.1ml (DRUG), Prevantics Maxi Swabstick (DRUG).
Who is sponsoring clinical trial NCT03861780?
This trial is sponsored by Professional Disposables International, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03861780 being conducted?
This trial has 1 study location across Montana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.